Robert Lorne Hopfner - 02 Jun 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
/s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
02 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 18:51:50 UTC
Next filing
24 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 -15,000 -50% $0.000000 15,000 02 Jun 2021 Common Stock 15,000 $21.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest monthly and fully vest on the earlier of June 2, 2022 or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.